share_log

Intelligent Bio Solutions | 3: Initial statement of beneficial ownership of securities-Director Fraser Nicola Marion

Intelligent Bio Solutions | 3: Initial statement of beneficial ownership of securities-Director Fraser Nicola Marion

Intelligent Bio Solutions | 3:首次持股聲明-董事 Fraser Nicola Marion
美股sec公告 ·  06/18 17:33
Moomoo AI 已提取核心訊息
Nicola Marion Fraser, a director and 10% owner of Intelligent Bio Solutions Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC on June 17, 2024. The Form 3 filing, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Fraser does not beneficially own any non-derivative or derivative securities of the company. The event requiring the statement occurred on June 7, 2024. The filing was completed by Fraser individually and was submitted to the SEC's Washington, D.C. office.
Nicola Marion Fraser, a director and 10% owner of Intelligent Bio Solutions Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC on June 17, 2024. The Form 3 filing, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Fraser does not beneficially own any non-derivative or derivative securities of the company. The event requiring the statement occurred on June 7, 2024. The filing was completed by Fraser individually and was submitted to the SEC's Washington, D.C. office.
Nicola Marion Fraser,智能生物解決方案有限公司的董事和10%的股東,在2024年6月17日向美國證券交易委員會提交了一份初步有益所有權報告。這份Form 3申報是《1934年證券交易法》第16(a)條要求的內容,表明Fraser沒有獲得公司任何非衍生或衍生證券的有益所有權。需要提交報告的事件發生在2024年6月7日。該申報由Fraser個人完成,並提交給SEC的華盛頓特區辦事處。
Nicola Marion Fraser,智能生物解決方案有限公司的董事和10%的股東,在2024年6月17日向美國證券交易委員會提交了一份初步有益所有權報告。這份Form 3申報是《1934年證券交易法》第16(a)條要求的內容,表明Fraser沒有獲得公司任何非衍生或衍生證券的有益所有權。需要提交報告的事件發生在2024年6月7日。該申報由Fraser個人完成,並提交給SEC的華盛頓特區辦事處。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息